Clinical Trial Update: The Clinical Efficacy and the Changes of Immune Cells Subsets With Bioagents in Ankylosing Spondylitis Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating clinical efficacy and immune cell subset changes with bioagents in ankylosing spondylitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis

Snippet

Sponsor: Qilu Hospital of Shandong University | Conditions: Ankylosing Spondylitis | Phase 4 | Status: UNKNOWN